Skip to content
Recruiting

Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps

About this study

This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.

Condition
Colorectal Carcinoma
Tested
Best Practice, Communication Intervention, Communication Intervention, Communication Intervention, Interview, Interview
Sponsor
Jonsson Comprehensive Cancer Center

Who can join

Age
21 years and older
Sex
All sexes
Healthy volunteers
Accepted

Inclusion 7

  • Minimum age: 21 years
  • Study condition: Colorectal Carcinoma
  • AIM 1 PATIENTS: Patients between age 45 and 75 with a HRN diagnosis in the past 5 years
  • AIM 1 PATIENTS: 12 patients who did and 12 patients who did not have surveillance colonoscopy
  • AIM 1 PROVIDERS: Primary care providers (PCPs) and gastroenterologists (GIs)
  • AIM 1 ADMINISTRATORS: Administrators who are involved in care processes related to CRC screening, HRN surveillance, and/or colonoscopy scheduling
  • AIM 2: Patients age 45 to 75 diagnosed with a HRN during the pre-specified two-year HRN diagnosis period

Exclusion 2

  • AIM 2: Individuals with a personal history of colorectal carcinoma (CRC), inflammatory bowel disease (Crohn's, ulcerative colitis), or polyposis syndrome
  • AIM 2: HRN cases not confirmed by chart review (human-in-the-loop)

Where

1 site, 1 recruiting

UCLA / Jonsson Comprehensive Cancer Center

Los Angeles, California, United States

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.